| Mrs Christina N Lawrenz, RPH | |
|
325 Maine St, Lawrence, KS 66044-1360 | |
| (785) 505-6445 | |
| (785) 505-6447 |
| Full Name | Mrs Christina N Lawrenz |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 325 Maine St, Lawrence, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811287485 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 11825 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Christina N Lawrenz, RPH 325 Maine St, Lawrence, KS 66044-1360 Ph: (785) 505-6445 | Mrs Christina N Lawrenz, RPH 325 Maine St, Lawrence, KS 66044-1360 Ph: (785) 505-6445 |
News Archive
In a small, preliminary study of regular migraine sufferers, scientists have found that measuring a fat-derived protein called adiponectin (ADP) before and after migraine treatment can accurately reveal which headache victims felt pain relief.
A study released this week suggests that anti-cancer chemotherapies which use nanoparticles to deliver drugs deep inside tumor tissue will be more effective if the particles are positively electrically charged because they are taken up to a greater extent by proliferating cells, according to a team of chemists and chemical engineers at the University of Massachusetts Amherst.
Nightingale's blood test can replace many routine blood tests currently used in healthcare (e.g. glucose tests). Additionally, Nightingale's service provides other blood biomarkers that can enhance disease risk prediction.
Novartis today presented results from a pivotal Phase III clinical trial exploratory subgroup analysis showing a 7.8-month improvement in median progression-free survival when using Farydak in combination with bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma who had received two or more prior regimens, including bortezomib and an immunomodulatory agent.
A study led by researchers from the University of California, San Diego School of Medicine has found a correlation between vitamin D3 serum levels and subsequent incidence of Type 1 diabetes.
› Verified 6 days ago
Jakob Ready, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3421 W 6th St, Lawrence, KS 66049 Phone: 785-841-9000 | |
Carrie Lynn Williams, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2336 Ridge Ct, Ste C, Lawrence, KS 66046 Phone: 785-841-1950 Fax: 785-841-1051 | |
William J Anderson, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1410 Kasold Dr, Ste A16, Lawrence, KS 66049 Phone: 785-843-8555 Fax: 785-843-0645 | |
Nikita Gandhi, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2300 Iowa St, Lawrence, KS 66046 Phone: 785-832-1112 | |
Dr. Michelle Wessling, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 325 Maine St, Lawrence, KS 66044 Phone: 785-505-5127 | |
Bridget Ellen Gillespie, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 400 W 23rd Street, Lawrence, KS 66046 Phone: 785-832-8388 | |
Lauren Dick, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1016 Lakecrest Rd, Lawrence, KS 66049 Phone: 785-218-9287 |